(Q80252475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Use of pairwise marker combination and recursive partitioning in a pharmacogenetic genome-wide scan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

L L Warren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A R Hughes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

E H Lai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

S A Haneline

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A T Bansal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A W Wooster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

W R Spreen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

J E Hernandez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

T R Scott

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A D Roses

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

M Mosteller

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

CNA30027 and CNA30032 study teams

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

12 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

180-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16969363%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500414

30 December 2019

exact match

0 references

cites work

Pharmacogenetics and the future of medical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Pharmacogenetics and drug development: the path to safer and more effective drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Pharmacogenetics and disease genetics of complex diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Moving towards individualized medicine with pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Pharmacogenetics in the laboratory and the clinic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Genotyping as a tool to predict adverse drug reactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Pharmacogenetics to predict drug-related adverse events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Genetic susceptibility to adverse drug reactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Recursive partitioning analysis of complex disease pharmacogenetic studies. I. Motivation and overview

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Replication validity of genetic association studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

A comprehensive review of genetic association studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

The replication requirement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Improved use of SNP information to detect the role of genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

MDR and PRP: A Comparison of Methods for High-Order Genotype-Phenotype Associations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021

Large recursive partitioning analysis of complex disease pharmacogenetic studies. II. Statistical considerations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500414

7 January 2021